Progress in the Treatment of Tourette Syndrome
Wenyan Jiao
Department of Psychology, Shaanxi Provincial People's Hospital (SPPH), Xi 'an, China.
Muhammetaly Agamedov
Department of Neurology and Neurosurgery, Ashgabat, Turkmenistan.
Guvanch Kerimov
National Center of Neurology, Ministry of Health of Turkmenistan, Ashgabat, Turkmenistan.
Jiaru Zheng
Xi 'an Medical University, Xi’an, China.
Stefan Bittmann
Department of Pediatrics, Ped Mind Institute, Hindenburgring 4, D-48599 Gronau, Germany.
Begench Annaye
Hospital with scientific Clinical Centre of Cardiology, Ashgabat, Turkmenistan.
Fuyong Jiao *
Children’s Hospital of SPPH, Xi’an, China.
*Author to whom correspondence should be addressed.
Abstract
Tourette Syndrome, a persistent neuropsychiatric condition predominantly encountered in childhood, significantly influences an individual's behavior, social engagement, and daily life activities. Current therapeutic strategies for managing Tourette Syndrome can broadly be classified into two primary categories: (1) pharmacological interventions, relying on medication, and (2) non-pharmacological approaches, which do not involve drug usage. This paper aims to delve into the existing literature on both these treatment modalities, with a primary emphasis on providing updated insights into pharmacological interventions.
Object: To investigate the methodology of treating children with Tourette Syndrome.
Methods: Collected 19 English references through a retrospective review of new treatment methods on the internet.
Results: Treatments are divided into two categories: drug treatment and non-drug treatment, with drug treatment being the primary focus.
Conclusion: The two categories of therapy have different curative effects and must be chosen in accordance with the actual clinical situation of patients.
Keywords: Tourette syndrome, child, nervous, treatment